Department of Pharmaceutical Analysis, School of Pharmacy, Air Force Medical University, Xi'an 710032, China.
Health Science Center, Xi'an Jiaotong University, Xi'an 710032, China.
Molecules. 2021 Nov 26;26(23):7169. doi: 10.3390/molecules26237169.
Poly(benzyl malate) (PBM), together with its derivatives, have been studied as nanocarriers for biomedical applications due to their superior biocompatibility and biodegradability. The acquisition of PBM is primarily from chemical routes, which could offer polymer-controlled molecular weight and a unique controllable morphology. Nowadays, the frequently used synthesis from L-aspartic acid gives an overall yield of 4.5%. In this work, a novel synthesis route with malic acid as the initiator was successfully designed and optimized, increasing the reaction yield up to 31.2%. Furthermore, a crystalline form of PBM (PBM-2) that polymerized from high optical purity benzyl-β-malolactonate (MLABn) was discovered during the optimization process. X-ray diffraction (XRD) patterns revealed that the crystalline PBM-2 had obvious diffraction peaks, demonstrating that its internal atoms were arranged in a more orderly manner and were different from the amorphous PBM-1 prepared from the racemic MLABn. The differential scanning calorimetry (DSC) curves and thermogravimetric curves elucidated the diverse thermal behaviors between PBM-1 and PBM-2. The degradation curves and scanning electron microscopy (SEM) images further demonstrated the biodegradability of PBM, which have different crystal structures. The hardness of PBM-2 implied the potential application in bone regeneration, while it resulted in the reduction of solubility when compared with PBM-1, which made it difficult to be dissolved and hydrogenated. The solution was therefore heated up to 75 °C to achieve benzyl deprotection, and a series of partially hydrogenated PBM was sequent prepared. Their optimal hydrogenation rates were screened to determine the optimal conditions for the formation of micelles suitable for drug-carrier applications. In summary, the synthesis route from malic acid facilitated the production of PBM for a shorter time and with a higher yield. The biodegradability, biosafety, mechanical properties, and adjustable hydrogenation widen the application of PBM with tunable properties as drug carriers.
聚(苯甲酰基苹果酸酯)(PBM)及其衍生物因其优异的生物相容性和生物降解性而被研究作为生物医学应用的纳米载体。PBM 的获得主要来自化学途径,这可以提供聚合物控制的分子量和独特的可控形态。如今,经常使用 L-天冬氨酸合成法得到的总产率为 4.5%。在这项工作中,成功设计并优化了一种以苹果酸为引发剂的新型合成路线,将反应产率提高到 31.2%。此外,在优化过程中发现了一种由高光学纯度苯甲酰基-β-苹果酸内酯(MLABn)聚合而成的 PBM 晶型(PBM-2)。X 射线衍射(XRD)图谱表明,结晶 PBM-2 具有明显的衍射峰,表明其内部原子排列更加有序,与由外消旋 MLABn 制备的无定形 PBM-1 不同。差示扫描量热法(DSC)曲线和热重曲线阐明了 PBM-1 和 PBM-2 之间不同的热行为。降解曲线和扫描电子显微镜(SEM)图像进一步证明了具有不同晶体结构的 PBM 的生物降解性。PBM-2 的硬度表明其在骨再生中的潜在应用,而与 PBM-1 相比,其溶解度降低,使其难以溶解和氢化。因此,将溶液加热至 75°C 以实现苯甲酰基的脱保护,并随后制备了一系列部分氢化的 PBM。筛选出它们的最佳氢化率,以确定适合药物载体应用的胶束形成的最佳条件。总之,从苹果酸合成路线促进了 PBM 的生产,缩短了生产时间,提高了产率。可生物降解性、生物安全性、机械性能和可调的氢化拓宽了具有可调性能的 PBM 作为药物载体的应用范围。